Sublingual Fentanyl for the Management of Breakthrough Pain
Status:
Terminated
Trial end date:
2019-11-04
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if an investigational dose of fentanyl
sublingual spray (FSS) can help to control pain in patients with advanced cancer when given
in an outpatient and inpatient setting.